antibody level – Page 7 – Communicable Diseases Research

Prior infection by seasonal coronaviruses, as assessed by serology, does not prevent SARS-CoV-2 infection and disease in children, France, April to June 2020

혈청학으로 평가한 계절성 코로나바이러스에 의한 이전 감염은 어린이의 SARS-CoV-2 감염 및 질병을 예방하지 못합니다. 프랑스, 2020년 4월~6월

Research

Published on 2021-04-012022-09-12
Journal: Eurosurveillance [Category] MERS, SARS, 진단,

Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infection

SARS-CoV-2 감염 환자에서 감염 후 최대 8개월까지 IgG 항-뉴클레오캡시드 항체의 종단 추적

Multicenter Study

Published on 2021-03-012022-09-11
Journal: Journal of Clinical Virology [Category] MERS, SARS, 진단, 치료법,

[키워드] Abbott anti-N IgG anti-nucleocapsid antibody antibodies antibody antibody level antibody levels Architect collected coronavirus COVID-19 Critical decrease develop eight first positive Follow-up hospitals IgG IgG antibodies IgG antibody immunoassay Immunoglobulin Immunoglobulin G Infection longitudinal Longitudinal studies Mild mild patient mild patients moderate MOST patients PCR PCR-confirmed positive remained retrospective SARS-CoV-2 SARS-CoV-2 infected patient seroconverted seronegative severe COVID-19 severe COVID-19 patients Severe patient severe patients shown significantly higher significantly lower steadily decreased symptom onset university was performed were measured windows within 6 months
[DOI] 10.1016/j.jcv.2021.104765 PMC 바로가기 [Article Type] Multicenter Study

Evolution of antibody immunity to SARS-CoV-2

SARS-CoV-2에 대한 항체 면역의 진화

Article

Published on 2021-03-012022-09-11
Journal: Nature [Category] Fulltext, SARS, 변종, 진단,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus affected Analysis animal model animal models antibody antibody immunity antibody level antibody levels Antigen assays asymptomatic individual Asymptomatic individuals B cells biopsy bowel Cell Cohort coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 death decrease Evolution examined Express greater humoral Humoral response IgA IgG antibodies IgM and IgG immunofluorescence immunoreactivity individual individuals Infection infection with SARS-CoV-2 intestinal intestinal biopsies knowledge less levels of antibody memory memory B memory B cell memory B cells memory response Neutralizing activity nucleic acids PCR persistence plasma PROTECT pseudotype virus RBD RBD mutation RBD mutations RBD-specific memory B cells Receptor-binding domain Reinfection required respiratory responsible SARS-CoV-2 SARS-CoV-2 nucleic acid severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 significantly Spike protein the antibody the receptor-binding domain the spike protein titre titres
[DOI] 10.1038/s41586-021-03207-w PMC 바로가기 [Article Type] Article

Antibody Response of an H9 Subtype Avian Influenza Poultry Vaccine on Three Kinds of Wild Birds in Shanghai Zoo

Article

Published on 2021-03-012023-06-22
Journal: Avian diseases [Category] 조류인플루엔자,

[키워드] antibody level H9 subtype avian influenza virus Shanghai Zoo zoo birds.
[DOI] 10.1637/aviandiseases-D-20-00094

Interplay of Antibody and Cytokine Production Reveals CXCL13 as a Potential Novel Biomarker of Lethal SARS-CoV-2 Infection

항체와 사이토카인 생산의 상호작용으로 CXCL13이 치명적인 SARS-CoV-2 감염의 잠재적인 신규 바이오마커로 밝혀짐

Research Article

Published on 2021-01-202022-09-10
Journal: mSphere [Category] 바이오마커, 진단, 치료법,

[키워드] Activation age Alpha Analysis analyzed anti-SARS-CoV-2 antibody antibodies antibody antibody level antibody levels Antigen antigens B cell Biomarker Blood blood type chemokine chemokine CXCL13 chemotactic marker chemotactic markers Course COVID-19 COVID-19 disease COVID-19 patient COVID-19 patients COVID-19 virus CXCL13 cytokine Cytokine analysis cytokine response Cytokines develop disease disease severity elevated Eotaxin exhibited explain gamma interferon Germinal center healthy individuals help identify IFN-γ IL-12 IL-18 IL-2 IL-4 IL-6 IL-8 immune immune response immune system Immunity immunological Immunological response Increases increases in Infection information interferon interleukin interleukin 6 involved IP-10 knowledge lethal magnitude majority marker maturation MIP-1α Necrosis novel nucleocapsid outcomes Patient patient mortality patients who survived populations Potential produced Production proinflammatory Protein provide RANTES RBD Receptor binding domain S1 subunit SARS-CoV-2 SARS-CoV-2 antigen SARS-CoV-2 antigens SARS-CoV-2 immunity SARS-CoV-2 pandemic SARS-CoV-2 patient SARS-CoV-2 patients severe COVID-19 Sex significant level specificity specimens systemic immune response TNF-α Tumor tumor necrosis tumor necrosis factor tumor necrosis factor alpha Variation Viral Viral proteins
[DOI] 10.1128/mSphere.01324-20 PMC 바로가기 [Article Type] Research Article

IgA2 Antibodies against SARS-CoV-2 Correlate with NET Formation and Fatal Outcome in Severely Diseased COVID-19 Patients

SARS-CoV-2에 대한 IgA2 항체는 중증 COVID-19 환자의 NET 형성 및 치명적인 결과와 상관 관계가 있습니다

Communication

Published on 2020-12-122022-09-11
Journal: Cells [Category] MERS, SARS, 바이오마커, 진단,

[키워드] activate acute respiratory syndrome acute respiratory syndrome coronavirus Adaptive immune response anti-SARS-CoV-2 anti-SARS-CoV-2 IgG antibody antibody level antibody levels C-reactive protein C-reactive protein (CRP characterized circulating contribute Control coronavirus correlated COVID-19 CRP level CRP levels extracellular DNA Formation Hospitalization Host ICU IgA IgA2 IgG response IgG responses Immune cell immune cells induce Infection Inflammation intensive care intensive care unit leads less marker mild symptoms moderate moderate symptoms NET neutrophil Neutrophil extracellular trap neutrophil extracellular trap (NET) organ injury outcome Patient patient groups patients plasma sample plasma samples respiratory SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 spike protein SARS-CoV-2-infected patient SARS-CoV-2-infected patients SARS-CoV-2-specific IgG severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 severe disease severe SARS severe SARS-CoV-2 specific antibodies Spike protein Symptom the strongest These data TRAP were measured while
[DOI] 10.3390/cells9122676 PMC 바로가기 [Article Type] Communication

Characterization of a Pan-Immunoglobulin Assay Quantifying Antibodies Directed against the Receptor Binding Domain of the SARS-CoV-2 S1-Subunit of the Spike Protein: A Population-Based Study

Article

Published on 2020-12-092022-10-30
Journal: Journal of Clinical Medicine [Category] COVID-19,

[키워드] 95% CI 95% confidence interval acute respiratory syndrome antibody antibody level antibody reactivity area under the curve association Characteristics characterization Clinical characteristics clinically coronavirus coronavirus disease COVID-19 cross-reactivity detect diagnostic Diagnostic accuracy disease severity electrochemiluminescence immunoassay Epitopes evaluate Evidence Fever Follow-up help hospitalized patient identify IgA IgG IgM immunoassay individual interquartile range IQR Laboratory median offer Outpatient Patient predictive values proportion Quantitative RBD Receptor binding domain SARS-CoV-2 SARS-COV-2 infection sensitivity sera serology significantly increased smoker smoking specificity sustained symptom onset symptomatic tested the S1 subunit the SARS-CoV-2 the Spike the spike protein without symptom
[DOI] 10.3390/jcm9123989 PMC 바로가기 [Article Type] Article

Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19

COVID-19로 입원한 환자의 혈청 내 전혈성 자가항체

Research Article

Published on 2020-11-182022-09-10
Journal: Science Translational Medicine [Category] 진단, 치료제,

[키워드] accelerated activated neutrophil Activation antibodies antibody antibody level antibody levels antiphospholipid antibodies autoantibodies autoantibody Autoimmune diseases blood vessel blood vessels Case series Casting circulating Coagulation coagulation pathway COVID-19 COVID-19 patient serum Cutoff develop eight ELISA FIBRIN filtration rate fraction glomerular filtration rate glycoprotein healthy individuals high risk Histopathology hyperactivity IgG IgG and IgM IgM in vitro injected injection Lung histopathology Lupus mice Mouse models NET NETs neutrophil Neutrophil extracellular trap Neutrophil extracellular traps Neutrophils Occlusion pathogenic pathogenic autoantibodies pathogenic autoantibody pathway Patient patients patients hospitalized patients with COVID-19 phenotype phospholipid Phospholipids Platelet platelet counts positive potential therapeutic target potentially life-threatening promoted Protein prothrombin prothrombotic purified respiratory Respiratory disease reveal serum serum sample serum samples severe COVID-19 severe respiratory disease small blood vessel small blood vessels syndrome the disease threshold Thrombophilia thrombosis thrombotic venous Venous thrombosis with COVID-19
[DOI] 10.1126/scitranslmed.abd3876 PMC 바로가기 [Article Type] Research Article

Compassionate use of convalescent plasma for treatment of moderate and severe pneumonia in COVID-19 patients and association with IgG antibody levels in donated plasma

Research article

Published on 2020-09-092022-10-05
Journal: EClinicalMedicine [Category] 치료법,

Convalescent plasma treatment for SARS-CoV-2 infection: analysis of the first 436 donors in England, 22 April to 12 May 2020

Rapid Communication

Published on 2020-07-162022-10-31
Journal: Eurosurveillance [Category] COVID-19, SARS,